Darktrace was founded in Cambridge, UK, in 2013 by mathematicians and machine learning specialists from the University of Cambridge, together with world-leading intelligence experts from MI5 and GCHQ, to bring transformative technology to the challenge of cyber security.
With this unique combination of expertise in mathematics, software and intelligence, Darktrace has delivered the world’s first operational Enterprise Immune System. Our leading-edge solution gives organizations the ability to detect emerging cyber-threats, allowing them the opportunity to proactively defend against in-progress cyber-attacks.
Our executive team has extensive experience in government intelligence and cyber operations and the protection of critical national infrastructure. This team is supported by a specialist cyber analyst team, with unparalleled experience of some of the most sophisticated threats in today’s complex security environment.
Darktrace has experienced rapid growth since its foundation, growing revenues by over 140% year-over-year, and recruiting over 620 employees working across 32 global offices. It was named ‘Best Security Company of the Year 2016’ at the Info Security Global Excellence Awards and a Gartner ‘Cool Vendor’ 2015.
We have raised over $175 million in funding from investors including Invoke Capital, Talis Capital, Hoxton Ventures, Summit Partners, KKR, Softbank, TenEleven, Samsung and Insight Venture Partners.
Darktrace is headquartered in Cambridge, UK and San Francisco, with global offices in New York, Auckland, London, Milan, Mumbai, Paris, Seoul, Singapore, Sydney, Tokyo, Toronto and Washington D.C.